Adagio Medical
Clinical trials sponsored by Adagio Medical, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Freezing heart tissue to stop lethal rhythms: new trial launches Results expected Jan 2027 (estimated)
- Freezing heart troubles: new device aims to stop ventricular tachycardia Results expected Mar 2027 (estimated)
- Freezing out deadly heart rhythms: new device under study Results expected May 2027 (estimated)
-
New freezing device tackles stubborn heart rhythm disorder
Disease control CompletedThis study tested a device called iCLAS™ that uses extreme cold to destroy tiny areas of heart tissue causing persistent atrial fibrillation (AFib). 215 adults with AFib lasting more than 7 days but less than a year received the procedure. Researchers tracked safety issues like h…
Sponsor: Adagio Medical • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New heart zapping tech tested for stubborn AFib
Disease control CompletedThis study tested two new devices that use energy pulses to treat persistent atrial fibrillation (a type of irregular heartbeat). 89 adults who had not responded to medication received a heart ablation procedure. The goal was to see if the devices are safe and can stop abnormal h…
Sponsor: Adagio Medical • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Freezing heart tissue may stop deadly rhythms
Disease control CompletedThis study tested a new freezing method (cryoablation) to treat a fast, dangerous heart rhythm called ventricular tachycardia. 64 adults who had not responded well to medication took part. The goal was to see if freezing the small area causing the problem could safely stop the rh…
Sponsor: Adagio Medical • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC